Company AnalysisAnalysis as of 30 Mar 2026

AI-generated · cited to primary sources · not investment advice · How we research

Tata Elxsi

BSE:500408
NSE:TATAELXSI

Our verdict on Tata Elxsi isn’t the consensus take — see where we landed, and the one risk the bull case glosses over.

See the verdict — free →
01 · Management Credibility

Does management do what it says?

In progressGenerative AI Enterprise Adoption Wave
60/100

Management confirmed a strong deal pipeline and ongoing investments in AI/GenAI technologies during the Q1 update. (2 in progress across 2 tracked commitments)

We are entering the new financial year with a strong commitment for growth... This is backed by strong customer relationships, addition of marquee logos, large deal wins, especially in SDV, investments in AI and GenAI, and a strong deal pipeline for the year ahead.

Tata Elxsi · Investor PPT · Apr 2024 · p.3
MissedMargin Stability Despite Wage Pressure
52/100

Management confirmed that junior to mid-level salary hikes were implemented effective July 1st, with a 120 basis point impact on margins. (2 met, 3 missed across 5 tracked commitments)

So we are definitely looking to come back to the margins for the full year that we delivered in the last financial year. So I think that is what we would focus on.

Tata Elxsi · Concall Transcript · Apr 2024 · p.8
GCC Advisory and Co-Creation Opportunity

Tata Elxsi is expanding its presence in Pune with a new center designed to house over 1000 engineers for automotive R&D. — target: >1000 engineers

It will house over 1000 engineers, designers and technology specialists, and advanced labs to spearhead collaborative initiatives in engineering R&D across Software Defined Vehicles, Connected Services, Autonomous Technologies, Electrification, Mechatronics, and Design.

Tata Elxsi · Investor PPT · Apr 2024 · p.30
Deal Win Rate and Conversion

Management expects a previously delayed large automotive deal to begin ramping up in the latter half of Q1 FY25. — target: Deal ramp-up (+1 more commitment)

So we're expecting that ramp up to happen in the later half of Q1.

Tata Elxsi · Concall Transcript · Apr 2024 · p.9
Platform and IP-Led Revenue Share

The company is investing in its Digital Therapeutics Platform TEcare to drive growth in the Healthcare segment. (+3 more commitments)

We are delighted to be launching our AVENIR SDV software suite at the CES 2025 Conference in Las Vegas, the premier global showcase for technology innovation.

Tata Elxsi · Investor PPT · Jan 2025 · p.4

See the full cited Management analysis of Tata Elxsi

Create free account →
02 · Business Model

How durable is the business?

US Enterprise IT Budget Recovery
72/100

The U.S. market is currently described as 'slow' and 'subdued' due to tariff uncertainties and discretionary spend pauses in healthcare and automotive sectors. (1 contracting, 3 expanding)

During this quarter, we performed well in key geographies of the U.S. and Europe with broad-based growth across key accounts and verticals, while India did see impact largely from the business from automotive suppliers.

Tata Elxsi · Concall Transcript · Jan 2026 · p.4
Employee Utilization Rate
62/100

Utilization dipped slightly to 70% as the company maintains a 'bench' of talent to service upcoming large deal ramp-ups, impacting short-term margins. (2 contracting, 2 expanding)

So we are operating at around 75% today. And we can go all the way up to 85%, right? So we are targeting to look at least moving around to 80%, before we start adding capacity and so on.

Tata Elxsi · Concall Transcript · Jan 2026 · p.9
Total Contract Value of Large Deals
60/100

The segment faced short-term headwinds as OEMs paused programs due to geopolitical and tariff uncertainties, though a major EUR 50M deal win provides long-term visibility. (2 contracting, 1 expanding)

Our automotive business witnessed challenges in the quarter as some OEMs and suppliers paused new program starts in the face of geopolitical and market uncertainties

Tata Elxsi · Concall Transcript · Apr 2025 · p.3
Other Findings
58/100

The India market share grew significantly from 17.6% to 19.8% year-on-year, indicating stronger domestic demand or better execution in the home market compared to global segments. (2 expanding, 3 contracting)

Incorporated in 1989, Tata Elxsi is amongst the world’s leading providers of design and technology services across industries including Transportation, Media, Communications and Healthcare & Medical Devices.

Tata Elxsi · Investor PPT · Jan 2026 · p.24
Utilization Rate Optimization
55/100

Margins have faced pressure due to revenue degrowth and transition costs of large deals; management is focusing on utilizing the 'bench' (available staff) to improve margins over the next three quarters. (1 contracting, 1 expanding)

EBITDA margin stood at 20.9%... we'll be able to utilize the bench at the same time, improving our margin as well.

Tata Elxsi · Concall Transcript · Jul 2025 · p.3

See the full cited Business Model analysis of Tata Elxsi

Create free account →
03 · Future Growth

Where does growth come from?

Platform and IP-Led Revenue Share
62/100

Tata Elxsi is co-developing 'Kavach 4.0', a next-generation train safety system, which opens a new growth path in the rail infrastructure market.

Tata Elxsi, along with Nova Technologies... will co-develop Kavach 4.0, the next-generation indigenous Automatic Train Protection (ATP) system.

Tata Elxsi · Investor PPT · Jan 2026 · p.19
Employee Utilization Rate
56/100

Utilization has improved from 66% to over 70%. Management has set a clear target to reach 75% by the end of the current fiscal year and 80% in the next, which will act as a major margin lever. (1 accelerating, 3 decelerating, 1 steady across 5 signals)

I am pleased with the operational excellence we demonstrated in improving margins, with EBIDTA growing to Rs. 222.2 crores, an increase of 220 bps QoQ. This was led by operational and delivery excellence, and improved utilisation.

Tata Elxsi · Investor PPT · Jan 2026 · p.4
Voluntary Attrition Rate (LTM)
33/100

The company is maintaining high retention (low attrition), which provides a stable base for future utilization improvements. (1 steady, 1 decelerating across 2 signals)

Attrition 12.4% [Q3'25] ... 15.6% [Q3'26]

Tata Elxsi · Investor PPT · Jan 2026 · p.9
US Enterprise IT Budget Recovery

The U.S. market is showing strong momentum with 7.9% sequential growth, while Europe remains the primary market. Japan is also cited as a very positive growth area. (2 accelerating across 2 signals)

we delivered strong quarter-on-quarter growth across key overseas markets led by U.S. market, which grew 7.9% quarter-on-quarter.

Tata Elxsi · Concall Transcript · Oct 2025 · p.3
Margin Stability Despite Wage Pressure

EBITDA margins are recovering from a dip in Q1, expanding by 70 basis points this quarter due to operational excellence. (3 accelerating, 2 reversing across 5 signals)

EBITDA & Margin (%) ... Q2'24 29.9% ... Q1'25 27.2% ... Q2'25 27.9%

Tata Elxsi · Investor PPT · Oct 2024 · p.5

See the full cited Future Growth analysis of Tata Elxsi

Create free account →
04 · Risk

What could break the thesis?

US Enterprise IT Budget Recovery
52/100

Global economic uncertainty (macro headwinds) continues to make clients cautious, leading to slower decision-making on new technology spending. [DEMAND]

Yes. So I think at a very, very high level, macro level, headwinds are still there, from an industry perspective... decision-making times are still a little bit slow.

Tata Elxsi · Concall Transcript · Jan 2026 · p.6
Employee Utilization Rate
37/100

Headcount reduction is now a deliberate strategy to improve utilization (currently at 70%) and manage costs during a demand slowdown, rather than an inability to hire. (2 easing, 2 stable)

So we are operating at around 75% today. And we can go all the way up to 85%, right? So we are targeting to look at least moving around to 80%

Tata Elxsi · Concall Transcript · Jan 2026 · p.9
Generative AI Enterprise Adoption Wave

While Media and Communications still saw a marginal decline, management indicates both sectors have 'bottomed out' with a clear line of sight for recovery starting in Q4 FY26. (1 easing)

Our Healthcare and Life Sciences business has bottomed out in the quarter... we're confident of bringing back growth in this business starting Q4 FY '26.

Tata Elxsi · Concall Transcript · Jan 2026 · p.4
Total Contract Value of Large Deals

The risk is intensifying in the short term as the top automotive customer has paused projects due to geopolitical and tariff uncertainties, though a new EUR 50M deal with a European OEM provides future diversification. (1 intensifying, 1 easing)

we have seen a number of projects that we are working on - especially with our top customer - witnessing pauses.

Tata Elxsi · Concall Transcript · Apr 2025 · p.5
Utilization Rate Optimization

Wage pressure is being offset by a shift in deal signatures toward 'best-cost' countries (offshore) and improving utilization of the existing bench rather than expensive lateral hiring. (1 easing)

The signature of the deals that we see going forward are a lot more on to best-cost countries rather than high-cost countries... we have been very selective in the type of people that we bring in.

Tata Elxsi · Concall Transcript · Apr 2025 · p.7

See the full cited Risk analysis of Tata Elxsi

Create free account →
Filing Analysis by Period

Tata Elxsi analysis by filing period

AI-generated informational research only. ThesisLoop is not investment advice, a stock recommendation, or a guarantee of returns.